How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like miRagen To Host Conference Call Discussing First Quarter 2017 Corporate Update And Financial Results May 2, 2017 Ablynx Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi July 19, 2017 Biotech Startup Bonanza Continues as Emerges With $30 Million September 18, 2017
miRagen To Host Conference Call Discussing First Quarter 2017 Corporate Update And Financial Results May 2, 2017
